NASDAQ · Medical - Healthcare Information Services

CARL (CARL) Stock

$12.93 +2.70% NASDAQ: CARL Healthcare

Valuation

MetricValue
Price$12.93
Market Cap$351.50M
P/E Ratio-5.71
P/B Ratio3.33
P/S Ratio5.83
EPS (TTM)$0.00
52-Week High$17.19
52-Week Low$8.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-30.30%
ROA-23.08%
ROCE-31.31%
Gross Margin-58.82%
Operating Margin-60.78%
Net Margin-58.80%
Debt/Equity0.19
Current Ratio9.07

Annual Financials (USD)

Metric202320242025
Revenue$14.0M$27.0M$51.0M
Operating Profit$-19.0M$-24.0M$-31.0M
Net Profit$-19.0M$-24.0M$-30.0M
EPS$-4.25$-1.50$-2.12
Op Margin-134.9%-88.8%-60.5%

Balance Sheet (USD)

Metric202320242025
Total Assets$14.0M$52.0M$130.0M
Total Liabilities$60.0M$122.0M$31.0M
Cash$7.0M$40.0M$86.0M
Borrowings$11.0M$17.0M$17.0M

Latest News

Carlsmed Inc. to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 Needham Initiates Carlsmed at Buy With $17 Price Target MT Newswires · Jul 1, 2026 Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High? Zacks · May 25, 2026 Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? Zacks · May 22, 2026 Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet Zacks · May 8, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-17.0M$-25.0M$-29.0M
Investing Cash Flow$0$0$-26.0M
Financing Cash Flow$0$0$100.0M
Net Cash Flow$-14.0M$33.0M$46.0M
Free Cash Flow$-18.0M$-26.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-10.42%
Quick Ratio11.67
Interest Coverage-31.00
Return 1Y-24.14%
Return 3Y—
Return 5Y—

Ownership

Insiders Held43.73%
Institutions Held40.57%
Institutions Float Held72.10%
Institutional HolderSharesReport Date
Orbimed Advisors LLC.1,252,6002026-03-31
Janus Henderson Group PLC1,227,4522026-03-31
Parkman Healthcare Partners LLC521,1232026-03-31
Blackrock Inc.446,8922026-03-31
Schonfeld Strategic Advisors Llc283,1802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About CARL

CARL is led by CEO Michael John Cordonnier, employs 100 people, headquartered in US, publicly traded since 2018.

CARL stock trades at $12.93 with a market capitalization of $351.50M. The stock is valued at a price-to-earnings (P/E) ratio of -5.71, price-to-book of 3.33, price-to-sales of 5.83. Over the past 52 weeks the stock has ranged between $8.50 and $17.19, and currently trades 24.8% below its 52-week high.

On profitability, CARL generates a return on equity (ROE) of -30.30%, return on capital employed of -31.31%, an operating margin of -60.78%, a net profit margin of -58.80%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides